Stem cell biotech MoglinBio secures seed investment
KIZOO Technology Ventures - 26-Oct-2022Kizoo is focused on rejuvenation biotech so it must see potential in normalizing CDC42 activity
Managing Director of Kizoo Technology Capital
Frank led the IPO of web.de, co-founded the Kizoo Venture Capital business together with Michael Greve and Matthias Hornberger, and since then helped numerous startups to grow. Among Frank’s other board-level assignments mostly at Kizoo portfolio companies, like Underdog Pharmaceuticals and Cellvie Inc., he is on the executive board of Atevia AG, a public company for 16 years, Chief Operating Officer of the Forever Healthy Foundation and co-founder of the Undoing Aging conference.
Previously, he was a strategy consultant with PriceWaterhouseCoopers. Frank holds a M.Sc. (New York) and a diploma in Business Administration and Engineering from Karlsruhe Institute of Technology (KIT), Germany.
Visit website: https://kizoo.com/#Schueler
See alsoDetails last updated 07-Apr-2022
Kizoo is focused on rejuvenation biotech so it must see potential in normalizing CDC42 activity
Initially targeting stiffened arteries in cardiovascular disease, this could have wider implications